Clinical Trial Update: A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating flexible dosing of paliperidone extended-release tablets in adults with schizophrenia has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone extended-release tablets (Paliperidone)

Snippet

Sponsor: Xian-Janssen Pharmaceutical Ltd. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2013-08-07